Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis

Background: Myasthenia Gravis (MG) is a rare autoimmune disease presenting with auto-antibodies that affect the neuromuscular junction. In addition to symptomatic treatment options, novel therapeutics include monoclonal antibodies (mAbs). IMGT<sup>®</sup>, the international ImMunoGeneTic...

Full description

Bibliographic Details
Main Authors: Rebecca Golfinopoulou, Véronique Giudicelli, Taciana Manso, Sofia Kossida
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/12/1756